Xyntha
Payments companies reported to CMS as associated with Xyntha. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xyntha, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xyntha
These are the largest totals companies reported as associated with Xyntha. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rajender Reddy | Hammonton, NJ | Internal Medicine | $10,406.25 |
| Barbara Konkle | Seattle, WA | Hematology (Internal Medicine) | $10,149.22 |
| Sofia Miranda | Miami, FL | Pediatrics (Nurse Practitioner) | $1,809.30 |
| Tracey Gaslin | Louisville, KY | Family | $620.74 |
| Vivek Sharma | Louisville, KY | Hematology & Oncology | $561.62 |
| Christopher Chan | Los Angeles, CA | Family | $299.63 |
| Doris Quon | Los Angeles, CA | Hematology (Internal Medicine) | $277.85 |
| Caitlyn Miller | West Chester, OH | Acute Care (Nurse Practitioner) | $238.15 |
| Jahnavi Gollamudi | Cincinnati, OH | Hematology (Internal Medicine) | $238.15 |
| Olufunmilayo Adewumi | Cincinnati, OH | Adult Health (Nurse Practitioner) | $212.46 |
Prescribed Xyntha?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.